Pharmacoepidemiology

Faculty

Timothy Anderson, MD, MAS

Dr. Timothy Anderson is a primary care physician and health services researcher whose primary research interests are identifying strategies to improve the quality and equity of care delivered to older adults with chronic conditions and to optimize medication use for patients in the hospital and at home.

Walid F. Gellad, MD, MPH

Director, Center for Pharmaceutical Policy and Prescribing

Dr. Gellad's research focuses on physician prescribing practices and on policy issues affecting access and adherence to medications for patients. Dr. Gellad is also a nationally recognized authority on improving the measurement of medication adherence.

C. Bernie Good, MD, MPH

As the Chair of the Medical Advisory Panel for Pharmacy Benefits Management for the Department of Veterans Affairs, Dr. Good has research interests relating to the safe, effective provision of medications. He has published recently in the area of drug safety, appropriate prescribing, conflicts of interest, and cost-effectiveness.

Wei-Hsuan "Jenny" Lo-Ciganic, PhD, MS, MSPharm

Dr. Lo-Ciganic is a pharmacoepidemiologist whose research focuses on improving drug safety, medication adherence, and the quality of prescribing, especially among vulnerable populations.

Jing Luo, MD, MPH

Dr. Luo is a health services researcher who conducts research on prescription drug use, pricing, and policy, especially for medicines treating chronic diseases such as diabetes. His work has been featured in The LancetThe New York Times, and The Washington Post.

Aimee Pickering, MD, MS

Dr. Pickering provides clinical care as a primary cary phsycian and teaching attending, while also conducting research on characterizing and reducing low-value care and subsequent care cascades and deprescribing low-value medications in older adults. She is particularly interested in applying implementation science principles to develop strategies to support deprescribing and in the de-implementation of other low-value practices.

Thomas R. Radomski, MD, MS

Dr. Radomski is a health services researcher and practicing general internist who conducts research on health care delivery, financing, and utilization. With a specific focus on developing and implementing novel, patient-centered approaches to systematically study and improve the value of healthcare in the United States, he is also interested in the value of prescription drug use in older adults and is developing, validating, and applying a patient-centered metric of low-value prescribing using administrative data.

Bryant Shuey, MD, MPH

Dr. Shuey is a board-certified internist and health services researcher whose work focuses on substance use and chronic disease, with an emphasis on evaluating policies affecting treatment access for opioid use disorder. 

Katie J. Suda, PharmD, MS, FCCP

Associate Director, Center for Pharmaceutical Policy and Prescribing
Associate Director, VA Center for Health Equity Research and Promotion

Dr. Suda’s area of research is pharmacoepidemiology, especially in the area of antimicrobials, and dual use of VA and non-VA health care. Currently, she is researching antibiotics and opioids in dental prescribing, including a focus on veteran health.